Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC
JTO Clinical and Research Reports（2021）
摘要
Additional evaluation of either sequence in a phase 3 trial is not warranted.
更多查看译文
关键词
Clinical trial,Immunotherapy,Metastatic non–small cell lung cancer,Immunotherapy and chemotherapy sequencing
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要